Predictions
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.43
23.01.22
23.01.22
-
23.01.23
23.01.23
7.21%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€4.70
05.11.20
05.11.20
-
05.11.21
05.11.21
170.32%
06.11.21
06.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€13.53
30.03.20
30.03.20
€29.00
04.11.21
04.11.21
72.28%
05.11.21
05.11.21
Canopy Growth Corp
Start price
Target price
Perf. (%)
€18.00
21.12.19
21.12.19
€30.00
04.11.21
04.11.21
-36.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Aphria Inc.
Start price
Target price
Perf. (%)
€4.29
25.11.19
25.11.19
-
04.11.21
04.11.21
196.12%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Aphria Inc.
Start price
Target price
Perf. (%)
€9.43
14.01.21
14.01.21
€28.00
72.92%
12.03.21
12.03.21
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Aphria Inc.
Start price
Target price
Perf. (%)
€13.38
08.03.21
08.03.21
€15.00
13.62%
10.03.21
10.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€20.95
10.02.21
10.02.21
€22.00
11.75%
11.02.21
11.02.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€7.48
11.01.21
11.01.21
-
11.01.22
11.01.22
39.14%
15.01.21
15.01.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.20
07.11.20
07.11.20
€6.40
23.49%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Aphria Inc.
Start price
Target price
Perf. (%)
€4.90
14.11.20
14.11.20
-
14.11.21
14.11.21
23.24%
27.11.20
27.11.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€4.27
14.07.20
14.07.20
€5.85
05.08.20
05.08.20
-5.09%
05.08.20
05.08.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€3.70
24.05.20
24.05.20
€5.00
26.06.20
26.06.20
-0.54%
26.06.20
26.06.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€42.32
29.01.19
29.01.19
€23.00
12.05.20
12.05.20
-66.80%
12.05.20
12.05.20
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€22.73
03.04.19
03.04.19
€27.06
12.03.20
12.03.20
-32.91%
12.03.20
12.03.20
Aphria Inc.
Start price
Target price
Perf. (%)
€7.73
16.04.19
16.04.19
€10.00
17.04.19
17.04.19
-6.47%
17.04.19
17.04.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€8.65
15.02.19
15.02.19
€10.00
13.03.19
13.03.19
-2.31%
13.03.19
13.03.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€6.14
24.01.19
24.01.19
€10.00
05.02.19
05.02.19
63.36%
05.02.19
05.02.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.59
11.01.19
11.01.19
€7.00
16.01.19
16.01.19
7.16%
16.01.19
16.01.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.02
28.12.18
28.12.18
€7.00
02.01.19
02.01.19
0.00%
02.01.19
02.01.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected